Cholestatic syndrome as initial manifestation of pancreatic metastasis of papillary thyroid carcinoma: case report and review

dc.TypeArticlept_BR
dc.contributor.authorTramontin, Mariana Yoshii
dc.contributor.authorFaria, Paulo Antonio Silvestre de
dc.contributor.authorNascimento, Cristina Moreira do
dc.contributor.authorBarbosa, Cibele de Aquino
dc.contributor.authorBarros, Maria de Fátima Rei Pereira
dc.contributor.authorBarros, Aniela Rodrigues Gomes de
dc.contributor.authorCarvalho, Rafaela Cardoso de
dc.contributor.authorCastro Neto, Antônio Kneipp Pitta de
dc.contributor.authorAndrade, Fernanda Accioly de
dc.contributor.authorVaisman, Fernanda
dc.contributor.authorBulzico, Daniel Alves
dc.contributor.authorMello, Rossana Corbo Ramalho de
dc.date.accessioned2022-08-17T11:54:58Z
dc.date.available2022-08-17T11:54:58Z
dc.date.issued2020
dc.descriptionp. 1-6.: tab. p&b,
dc.description.abstractMost papillary thyroid carcinomas (PTC) harbor excellent prognosis. Although rare, distant metastases normally occur in lungs and/or bones. Here we describe a rare case of pancreatic metastasis presenting with rapid onset cholestatic syndrome. A literature review was also performed. A 73-year old man with a high risk PTC was submitted to total thyroidectomy (TT) followed by radioiodine therapy. After initial therapy, he persisted with progressive rising serum thyroglobulin levels but with no evidence of structural disease. Recently, the patient presented with a rapid onset and progressive cholestatic syndrome. A 4 cm lesion in pancreas was identified, with echoendoscopy fine-needle aspiration biopsy (FNAB) confirming a pancreatic metastasis from PTC. The patient was submitted to a successful pancreaticoduodenectomy. Pancreatic metastases of PTC are rare and few long-term follow-up data are available to guide management. Fourteen cases were former reported, mean age was 65.7 years-old with mean time between PTC and pancreatic metastasis diagnosis of 7.9 years. Nine of them had another distant metastasis, nine were diagnosed by FNAB and just two received sorafenib.
dc.identifier.citationTRAMONTIN, Mariana Yoshii et al. Cholestatic syndrome as initial manifestation of pancreatic metastasis of papillary thyroid carcinoma: case report and review. Arch Endocrinol Metab., v. 64, n. 2, p. 1-6, 2020.
dc.identifier.issn2359-4292
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/10181
dc.publisherArch Endocrinol Metab.pt_BR
dc.subjectPâncreaspt_BR
dc.subjectPancreaspt_BR
dc.subjectCâncer Papilífero da Tireoidept_BR
dc.subjectThyroid Cancer Papillarypt_BR
dc.subjectColestasept_BR
dc.subjectCholestasispt_BR
dc.titleCholestatic syndrome as initial manifestation of pancreatic metastasis of papillary thyroid carcinoma: case report and reviewpt_BR

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Cholestatic syndrome as initial manifestation of pancreatic metastasis of papillary thyroid.pdf
Size:
133.04 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description: